Stockreport

Akari Therapeutics' (AKTX) CEO David Solomon on Q4 2017 Results - Earnings Call Transcript [Seeking Alpha]

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF Akari Therapeutics' (AKTX) CEO David Solomon on Q4 2017 Results - Earnings Call Transcript [Read more]